Express Scripts — Cigna's pharmacy benefit manager — said Thursday that it will expand low-copay access to GLP-1 agonist weight-loss drugs for participants in some of the prescription drug ...

Wegovy and Zepbound — two of three GLP-1 medications currently approved for weight loss in the U.S. — have monthly list prices of $1,349 and $1,060, respectively.

The monthly copay for GLP-1 weight loss medicines will be limited to no more than $200 under the new offering. Patients can save as much as $3,600 per year compared to buying these medications ...

The GLP-1 drugs are currently only covered by half of The Cigna Group (NYSE:CI)'s clients. Customers who now provide coverage could save as much as 20%.

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs By Bertha Coombs, CNBC • Published May 21, 2025 • Updated on May 21, 2025 at 6:19 pm ...

Dive Brief: Cigna is building on client demand for tools to support patients on GLP-1 weight loss drugs, announcing two new programs on Friday meant to improve clinical care around the dispensing ...

The insurer plans to cap annual price increases for the drugs, called GLP-1 receptor agonists, at 15% for employers and plans participating in a weight loss management program offered by its ...